Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Cash from Operations (2018 - 2025)

TransMedics (TMDX) has 8 years of Cash from Operations data on record, last reported at 34513000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 75.52% year-over-year to 34513000.0; the TTM value through Dec 2025 reached 192840000.0, up 295.14%, while the annual FY2025 figure was 192840000.0, 295.14% up from the prior year.
  • Cash from Operations reached 34513000.0 in Q4 2025 per TMDX's latest filing, down from 69573000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 91609000.0 in Q2 2025 and bottomed at 18406000.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 7696700.0, with a median of 4785500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: plummeted 151.11% in 2022, then surged 914.63% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 6648000.0 in 2021, then soared by 39.31% to 4035000.0 in 2022, then soared by 305.8% to 8304000.0 in 2023, then soared by 136.79% to 19663000.0 in 2024, then skyrocketed by 75.52% to 34513000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 34513000.0 in Q4 2025, 69573000.0 in Q3 2025, and 91609000.0 in Q2 2025.